Honluten
Khavinson natural peptide complex derived from lung tissue — used for chronic respiratory conditions, pulmonary rehabilitation, and bronchial mucosal restoration.
🔬 Mechanism of Action
Honluten is a Khavinson Cytomax derived from lung tissue, containing alveolar and bronchial peptides that regulate gene expression across the pulmonary epithelium. Unlike Taxorest (bronchial-specific), Honluten contains peptides from both airway and gas-exchange compartments.
Honluten modulates: (1) surfactant protein genes (SP-A, SP-B, SP-D) in type II pneumocytes for alveolar stability, (2) Clara cell secretory protein (CC16) for anti-inflammatory airway protection, (3) epithelial tight junction proteins (claudins, occludin) that maintain the air-blood barrier, and (4) local immune defense via secretory IgA and defensin expression.
Because it covers both bronchial and alveolar compartments, Honluten is sometimes preferred over Taxorest for general respiratory health maintenance.
Source: PMID: 15677927
📜Background & History
Honluten is the lung Cytomax extract, providing broad pulmonary peptide support.
🎯 Research Use Cases
- ✓Pulmonary function
- ✓Respiratory health
- ✓Chronic lung conditions
💉 Dosing Protocol
| Typical Dose | 1-2 capsules/day |
| Frequency | 1-2× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
⚠️Safety & Considerations
Standard oral Cytomax capsule protocol. Well tolerated.
⚡Interactions & Contraindications
Standard Cytomax capsule protocol.
🔗Synergies & Common Stacks
Honluten (lung Cytomax) + Bronchogen (synthetic bronchial) = comprehensive respiratory bioregulator support.